AHR and breast carcinoma: These treatments on MDA-MB-231 and T47D breast cancer cells led to the AhR-regulated overexpression of the miR-212/132 cluster, which, in turn, reduced migration, invasion, and metastasis through suppressing the pro-metastatic transcription factor SOX-4 that present binding sites for the miRNA cluster.